IPO
-
-
-
-
-
-
-
Intellia Therapeutics Names John Leonard, M.D., President and Chief Executive Officer
-
-
-
-
-
-
-
CRISPR (CRSP), Intellia (NTLA), Caribou, ERS Genomics Provide Update on CRISPR/Cas9 U.S. Patent Interference Proceedings
-
-
-
-
-
-
-
Intellia Therapeutics, Inc. (Nasdaq: NTLA) to Ring The Nasdaq Stock Market Opening Bell
-
-
-
122,340 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

